Medtronic's PillCam COLON 2 approved for expanded indication, FTC asks for more information on Pfizer-Allergan merger — 6 GI company key notes

Here are six recent news updates on key gastroenterology and endoscopy companies.

Takeda Pharmaceuticals is entering a multi-year research partnership with the University of Chicago and the Icahn School of Medicine at Mount Sinai in New York City to study inflammatory bowel disease.

The Federal Trade Commission is asking for more information from Pfizer and Allergan regarding their pending merger deal.

The Committee for Medicinal Products for Human Use of the European Medicines Agency granted accelerated review for Xilonix by XBiotech.

Connors Investor Services bought 435 additional shares of Cantel Medical during the fourth quarter period.

Medtronic's PillCam COLON 2 capsule was cleared by the FDA for an expanded indication.

Brighter Health Network and Medspira are partnering to further market, distribute and service Medspira's mcompass anorectal manometry system.

More articles on GI/endoscopy:
Connors Investor Services buys 435 Cantel Medical shares: 3 points
Dignity Health Medical Foundation adds Dr. Rafiq Sheikh: 3 notes
Dr. Shyam Dang joins Saline Memorial Hospital: 4 things to know

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months